ArticleMolecular and clinical oncology2019

Early tumor shrinkage as a predictive factor of metastatic renal cell carcinoma in molecular targeted therapy: A single institutional study.

Suguru Shirotake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.